Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | - | 5.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 2.22 | 1.4 |
NAV | ₹15.74 | ₹1901.79 |
Fund Started | 12 Jul 2022 | 08 Dec 1994 |
Fund Size | ₹894.15 Cr | ₹69639.05 Cr |
Exit Load | Exit load of 1%, if redeemed within 90 days. | Exit load of 1% if redeemed within 1 year
|
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 10.45% | 15.91% |
3 Year | - | 24.21% |
5 Year | - | 31.64% |
1 Year
3 Year
5 Year
Equity | 94.28% | 87.39% |
Cash | 4.27% | 11.01% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
HDFC Bank Ltd. | 9.15% |
ICICI Bank Ltd. | 7.93% |
Larsen & Toubro Ltd. | 5.83% |
Reliance Industries Ltd. | 5.04% |
Persistent Systems Ltd. | 4.67% |
Titan Company Ltd. | 4.42% |
Sun Pharmaceutical Industries Ltd. | 4.36% |
Infosys Ltd. | 4.14% |
Marico Ltd. | 4.09% |
Shriram Finance Ltd | 4.08% |
Name | Assets |
---|---|
ICICI Bank Ltd. | 9.58% |
HDFC Bank Ltd. | 9.45% |
Axis Bank Ltd. | 8.86% |
Kotak Mahindra Bank Ltd. | 5.14% |
SBI Life Insurance Company Ltd. | 4.33% |
Maruti Suzuki India Ltd. | 4.14% |
Cipla Ltd. | 3.98% |
Bharti Airtel Ltd. | 3.19% |
HCL Technologies Ltd. | 2.74% |
Piramal Pharma Ltd. | 2.62% |
Name | Trideep Bhattacharya | Dhruv Muchhal |
Start Date | 01 Oct 2021 | 14 Sep 2023 |
Name
Start Date
Description | The scheme seeks to generate long term capital appreciation by investing in equity and equity related instruments of upto 30 companies across market capitalisation. | The scheme seeks to generate capital appreciation / income from a portfolio, predominantly invested in equity & equity related instruments. |
Launch Date | 12 Jul 2022 | 08 Dec 1994 |
Description
Launch Date